Humacyte, Inc. (HUMA) Tops Q2 EPS by 57c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. LITE
5. CL
6. TFII
7. LYB
8. NVT
9. SPY
10. AAPL

Go back to Humacyte, Inc. (HUMA) Tops Q2 EPS by 57c

Humacyte Second Quarter 2022 Financial Results and Business Update

August 12, 2022 7:00 AM EDT

-- Human Acellular Vessels (HAVs) successfully implanted in wounded Ukrainian citizens and reported to be functioning, saving limbs

-- Hosted key opinion leader (KOL) webinar on HAV in the treatment of vascular trauma, featuring Ernest E. Moore, M.D and Gregory A. Magee, M.D.

-- Strengthened Board of Directors with appointment of Diane Seimetz, Ph.D. and leadership team with appointment of Shamik Parikh, M.D. as Chief Medical Officer

 -- Multiple scientific meeting presentations and publications highlighting clinical HAV data in vascular... More